<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04643145</url>
  </required_header>
  <id_info>
    <org_study_id>AE 201121</org_study_id>
    <nct_id>NCT04643145</nct_id>
  </id_info>
  <brief_title>Optimal Drainage After Flexible Ureterorenoscopy; Prospective Assessment of Perioperative Outcomes and Health-Related Quality of Life Through a Randomized Controlled Trial</brief_title>
  <official_title>Optimal Drainage After Flexible Ureterorenoscopy; Prospective Assessment of Perioperative Outcomes and Health-Related Quality of Life Through a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Flexible ureterorenoscopy (FURS) is now recommended for the treatment of kidney stones&#xD;
      smaller than 20 mm, as an alternative to extracorporeal shock wave lithotripsy (ESWL) and in&#xD;
      combination with percutanous nephrolithotomy (PCNL) for stones larger than 20 mm. At the end&#xD;
      of the operation, a ureteral drainage is put in place for the treatment of residual fragments&#xD;
      and the inflammation following the ureteroscopy. It helps prevent obstructive symptoms and&#xD;
      the development of strictures.&#xD;
&#xD;
      Drainage is done either by a ureteral catheter or by a double J stent. In the literature,&#xD;
      while drainage after ureteroscopy is recommended, the criteria for choosing between these two&#xD;
      options are not clearly defined.&#xD;
&#xD;
      The objective of this study will be to assess whether the type of postoperative drainage&#xD;
      after URS for kidney stones can influence the perioperative outcomes and health-related&#xD;
      quality of life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Flexible ureterorenoscopy (FURS) is now recommended for the treatment of kidney stones&#xD;
      smaller than 20 mm, as an alternative to extracorporeal shock wave lithotripsy (ESWL) and in&#xD;
      combination with percutanous nephrolithotomy (PCNL) for stones larger than 20 mm. At the end&#xD;
      of the operation, a ureteral drainage is put in place for the treatment of residual fragments&#xD;
      and the inflammation following the ureteroscopy. It helps prevent obstructive symptoms and&#xD;
      the development of strictures.&#xD;
&#xD;
      Drainage is done either by a ureteral catheter or by a double J stent. In the literature,&#xD;
      while drainage after ureteroscopy is recommended, the criteria for choosing between these two&#xD;
      options are not clearly defined.&#xD;
&#xD;
      The objective of this study will be to assess whether the type of postoperative drainage&#xD;
      after URS for kidney stones can influence the perioperative outcomes and health-related&#xD;
      quality of life.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Actual">December 15, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stone free rate</measure>
    <time_frame>12 weeks after the procedure</time_frame>
    <description>presence of residual fragments on non contrast computed tomography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>perioperative complications</measure>
    <time_frame>First 3 days postoperative</time_frame>
    <description>perioperative complications after the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain by visual analogue scale</measure>
    <time_frame>first 24 hours postoperatively</time_frame>
    <description>Visual analogue scale will be assessed postoperative</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Stones, Kidney</condition>
  <arm_group>
    <arm_group_label>Ureteral catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive ureteral catheter for 2 days after the procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Indwelling double J stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive indwelling double J stent for 2-4 weeks after the procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Flexible ureteroscopy for renal calculi less than 20 mm</intervention_name>
    <description>Patients with renal calculi less than 20 mm will be managed by flexible ureteroscopy. at the end of the procedure, they will be randomized to receive either temporary ureteral catheter for 2 days or indweeling double J stent for 2-4 weeks</description>
    <arm_group_label>Indwelling double J stent</arm_group_label>
    <arm_group_label>Ureteral catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1- Adult patients (aged &gt;18 years) 2- Undergo unilateral uncomplicated retrograde&#xD;
             intrarenal surgery (RIRS) using flexible ureterorenoscopy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Residual ureteral or renal stones after the procedure as documented by the surgeon&#xD;
&#xD;
          2. Patients who will need auxiliary procedures (ESWL , re-FURS or PCNL)&#xD;
&#xD;
          3. Preoperative febrile UTI&#xD;
&#xD;
          4. pregnancy or breastfeeding&#xD;
&#xD;
          5. Bilateral ureteroscopic surgery&#xD;
&#xD;
          6. Single kidney&#xD;
&#xD;
          7. Chronic kidney disease&#xD;
&#xD;
          8. Cardiovascular or cerebrovascular disease&#xD;
&#xD;
          9. Hepatic dysfunction&#xD;
&#xD;
         10. Other acute medical conditions as acute gastroenteritis, osetoarthritis that might&#xD;
             influence the patient QoL&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amr A Elsawy</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Urology and Nephrology Center</name>
      <address>
        <city>Mansoura</city>
        <state>DK</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>November 21, 2020</study_first_submitted>
  <study_first_submitted_qc>November 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2020</study_first_posted>
  <last_update_submitted>January 20, 2021</last_update_submitted>
  <last_update_submitted_qc>January 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Amr Abdel-Lateif El-Sawy</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Kidney stones</keyword>
  <keyword>Flexible ureteroscopy</keyword>
  <keyword>Quality of life</keyword>
  <keyword>drainage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

